window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 24, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Liza

  • Biotech,Clinical Trials,Drug Development,Oncology,Precision medicine,Research & Development

    NETRIS Pharma Nature publishes pancreatic cancer Phase 1b data showing NP137 survival and surgery gains

    Nature publishes Phase 1b data showing NETRIS Pharma’s NP137 improves [...]

    April 24, 2026
  • Biotech,Cell & Gene Therapy,Clinical Development,Drug discovery,Research & Development,Technology and platforms

    Myomaker Bio launches lab-grown human muscle platform for preclinical drug testing

    Myomaker Bio, a UK biotechnology company spun out from Loughborough [...]

    April 24, 2026
  • Biotech,Clinical Trials,European biotech,Events and Conferences,Gastroenterology

    Abivax to present nine obefazimod studies at DDW as Phase 3 ulcerative colitis data build

    Abivax will present nine scientific abstracts on obefazimod at Digestive [...]

    April 24, 2026
  • Clinical Development,Clinical studies,Digital Health,FDA,Medical devices,Technology and platforms

    Viz.ai, Johnson & Johnson strike US chronic subdural hematoma AI deal

    Viz.ai has entered a collaboration with Johnson & Johnson to [...]

    April 22, 2026
  • Clinical Development,Data Management,Mergers & Acquisitions,Regulatory Affairs,Research & Development

    Veristat acquires Certara regulatory and medical writing business

    Veristat has agreed to acquire Certara’s regulatory and medical writing [...]

    April 22, 2026
  • CDMOs & Manufacturing,Facilities and infrastructure,Medical devices,Regulatory Affairs,Supply Chain & Logistics

    Trelleborg gains ISO certification for Costa Rica medtech plant

    Trelleborg Medical Solutions has secured ISO 13485:2016 certification for its [...]

    April 22, 2026
  • CDMOs & Manufacturing,Drug discovery,Ingredients,Manufacturing,Sustainability,Technology and platforms

    Merck launches bio-based HPLC solvents for pharma labs

    Merck has launched a portfolio of bio-based solvents for high-performance [...]

    April 22, 2026
  • Clinical Development,Clinical Trials,Mental health,Neurosciences,Pharmaceuticals and therapeutics

    Alto starts Phase 2b ALTO-207 trial in treatment-resistant depression

    Alto Neuroscience has started a Phase 2b trial of ALTO-207 [...]

    April 22, 2026
  • Biotech,Cell & Gene Therapy,Clinical Development,Clinical Trials,Infectious Diseases,Pharmaceuticals and therapeutics

    ARTCLINE completes enrolment in septic shock trial for ARTICE therapy

    ARTCLINE has completed patient enrolment in a 142-patient randomized study [...]

    April 20, 2026
  • CDMOs & Manufacturing,Healthcare leadership,Market Access & Commercialization,Pharmaceuticals and therapeutics,Supply Chain & Logistics

    SGD Pharma highlights GLP-1 demand, supply chain pressure and sustainability focus at DCAT Week

    Interview with Carol Grassi Mircich, chief commercial marketing and innovation [...]

    April 20, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Neomorph raises $100 million to advance NEO-811 Phase 1/2 cancer trial and molecular glue degrader pipeline
    Categories: Biotech, Clinical Trials, Drug discovery, Funding, Oncology, Partnerships & Funding, Pharmaceuticals and therapeutics, Research & Development, Technology and platforms
  • NICE expands Lokelma access for hyperkalaemia after draft recommendation
    Categories: Cardiovascular diseases, Chronic diseases, Market Access & Commercialization, Pharmaceuticals and therapeutics, Regulatory Affairs
  • Oncodesign expands ARRONAX deal to secure astatine-211 supply for radiotherapy research
    Categories: CDMOs & Manufacturing, Drug Development, European biotech, Logistics and distribution, Oncology, Partnerships & Funding, Supply Chain & Logistics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top